AnalystsTim LugoTim Lugo's Stock Forecasts
AnalystsTim Lugo
Analyst Ranking
Bottom 5%
#5273 out of 5510 analysts
Average Return
-33.08%
Win Rate
31%5 out of 16
Risk vs Reward
Poor
Good
Tim Lugo's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Biohaven Pharmaceutical Holding Co LtdBHVN1 | +45.04% | $24.09 | $34.94 | 2017-05-30 - 2018-05-30 | Buy |
Zevra Therapeutics IncZVRA | +26.92% | $6.24 | $7.92 | 2024-03-12 - 2025-03-12 | Buy |
Lenz Therapeutics IncLENZ | +16.88% | $20.44 | $23.89 | 2024-04-15 - 2025-04-15 | Buy |
Abbvie IncABBV | +6.92% | $163.91 | $175.26 | 2024-01-29 - 2025-01-29 | Buy |
Xenon Pharmaceuticals IncXENE | +0.39% | $15.24 | $15.30 | 2020-01-08 - 2021-01-08 | Buy |
Tim Lugo Analyst Color
Get additional color on Tim Lugo's coverage of popular stocks
Tim Lugo's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Vistagen Therapeutics IncVTGN | 3 | Hold | N/A | N/A | Downgrades | 9 months ago |
Biomarin Pharmaceutical IncBMRN | 3 | Hold | N/A | N/A | Downgrades | 2 years ago |
Revance Therapeutics IncRVNC | 1 | Hold | N/A | N/A | Downgrades | 2 years ago |
Applied Therapeutics IncAPLT | 1 | Buy | N/A | N/A | Initiates Coverage On | 2 years ago |
Lenz Therapeutics IncLENZ | 1 | Buy | N/A | N/A | Initiates Coverage On | 2 years ago |
Solid Biosciences IncSLDB | 1 | Buy | $40.00 | N/A | Initiates Coverage On | 2 years ago |
Zevra Therapeutics IncZVRA | 1 | Buy | N/A | N/A | Initiates Coverage On | 3 years ago |
Abbvie IncABBV | 2 | Buy | N/A | N/A | Upgrades | 3 years ago |
Allakos IncALLK | 2 | Buy | N/A | N/A | Upgrades | 3 years ago |
Aclaris Therapeutics IncACRS | 1 | Hold | N/A | N/A | Downgrades | 3 years ago |
Travere Therapeutics IncTVTX | 1 | Hold | N/A | N/A | Downgrades | 3 years ago |
Ars Pharmaceuticals IncSPRY | 2 | Hold | N/A | N/A | Downgrades | 3 years ago |
Fresh Tracks Therapeutics IncFRTX | 1 | Buy | N/A | N/A | Initiates Coverage On | 5 years ago |
Adamas Pharmaceuticals IncADMS | 1 | Hold | N/A | N/A | Downgrades | 5 years ago |
Kinnate Biopharma IncKNTE | 1 | Buy | N/A | N/A | Initiates Coverage On | 5 years ago |
Sage Therapeutics IncSAGE | 1 | Hold | $62.00 | N/A | Downgrades | 5 years ago |
Atea Pharmaceuticals IncAVIR | 1 | Buy | N/A | N/A | Initiates Coverage On | 6 years ago |
Xenon Pharmaceuticals IncXENE | 1 | Buy | N/A | N/A | Initiates Coverage On | 7 years ago |
Akari Therapeutics PLCAKTX | 2 | Buy | N/A | N/A | Upgrades | 9 years ago |
Ovid Therapeutics IncOVID | 1 | Buy | N/A | N/A | Initiates Coverage On | 9 years ago |
Biohaven Pharmaceutical Holding Co LtdBHVN1 | 1 | Buy | $46.00 | N/A | Initiates Coverage On | 9 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.